Determined to combat the incidence of Substandard and Falsified (SF) medicines in the country, the National Agency for Food and Drug Administration and Control (NAFDAC) has engaged stakeholders in the pharmaceutical products supply chain. At a stakeholder’s meeting by NAFDAC on Thursday, NAFDAC’s Director General, Prof Mojisola Adeyeye emphasised the need to explore how to combat the sale and distribution …